| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Over the past 90 days, insiders at Adaptive Biotechnologies Corporation (ADPT) have been net sellers, shedding 1,417,892 shares worth roughly $30.5M on balance. In the past 30 days, 0 insiders bought and 3 sold. Sales set the recent tone.
Not all activity pointed one way: 3 insiders sold in the same window. Classified under Biotechnology (Health Care sector), ADPT's insider flows are most useful compared with peers in the same group.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 2.18M | $53.91M | - | |
| Other | 401.3K | $9.92M | -5,000 | |
| CFO | 256.7K | $6.35M | - | |
| Other | 230.7K | $5.70M | -105,762 | |
| Other | 113.5K | $2.81M | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec 22, 2021 | Cohen Chad M87 | Chief Financial Officer | Sale+OE | 10,000 | $30.00 | $300,000.00 | -31.6% | -54.6% | -72.5% | |
| Nov 18, 2021 | Robins Harlan S83 | Chief Scientific Officer | Sale+OE | 4,000 | $32.00 | $127,993.00 | -2.8% | -46.0% | -71.5% | |
| Nov 10, 2021 | Cohen Chad M87 | Chief Financial Officer | Sale+OE | 10,000 | $34.98 | $349,800.00 | -18.8% | -51.6% | -72.9% | |
| Oct 21, 2021 | Robins Harlan S83 | Chief Scientific Officer | Sale+OE | 11,200 | $33.71 | $377,561.00 | -3.8% | -48.3% | -80.9% | |
| Oct 8, 2021 | Adams R Mark88 | Chief Operating Officer | Sell | 3,125 | $33.16 | $103,629.95 | -2.9% | -28.4% | -78.1% | |
| Oct 8, 2021 | Robins Harlan S83 | Chief Scientific Officer | Sale+OE | 11,685 | $32.95 | $385,018.45 | -4.0% | -28.4% | -78.1% | |
| Oct 6, 2021 | Cohen Chad M87 | Chief Financial Officer | Sale+OE | 10,000 | $32.41 | $324,050.00 | -18.8% | -17.8% | -75.6% | |
| Sep 15, 2021 | Robins Harlan S83 | Chief Scientific Officer | Sale+OE | 11,685 | $36.98 | $432,054.00 | -2.7% | -27.4% | -76.9% | |
| Sep 10, 2021 | Robins Chad M62 | CEO And Chairman | Sell | 43,499 | $38.43 | $1,671,495.54 | -0.5% | -28.1% | -76.6% | |
| Sep 8, 2021 | Cohen Chad M87 | Chief Financial Officer | Sale+OE | 14,375 | $39.47 | $567,331.25 | -25.0% | -26.7% | -75.7% |